PATENT CLAIM ANALYSIS

Application Number: 16111378
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["544", "244000"]

Abstract:
The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.

Claim (Index 12):
The compound of  claim 1 , wherein R a  is aryl.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 96.0
- Lexical Diversity: 1.38235
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15179209', '15617841', '15809400', '14463908', '14874027']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8752126718777155
- 35 USC 102 Novelty (BERT): 0.6072756320499346
- Combined Prediction Score: 0.8484189678949374
- Mean Citation Score: 606.9477559999998
- Max Citation Score: 632.4096
- Similarity Product: 464.6190976501464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test